The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mancuso, G.
Right arrow Articles by Teti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mancuso, G.
Right arrow Articles by Teti, G.
The Journal of Immunology, 2004, 172: 6324-6329.
Copyright © 2004 by The American Association of Immunologists

Dual Role of TLR2 and Myeloid Differentiation Factor 88 in a Mouse Model of Invasive Group B Streptococcal Disease 1

Giuseppe Mancuso*, Angelina Midiri*, Concetta Beninati*, Carmelo Biondo*, Roberta Galbo*, Shizuo Akira{dagger}, Philipp Henneke{ddagger},§, Douglas Golenbock{ddagger} and Giuseppe Teti2,*

* Department of Pathology and Experimental Microbiology, University of Messina Medical School, Messina, Italy; {dagger} Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; {ddagger} Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605; and § Children’s Hospital, Freiburg University, Freiburg, Germany

Toll-like receptors (TLRs) are involved in pathogen recognition by the innate immune system. Different TLRs and the adaptor molecule myeloid differentiation factor 88 (MyD88) were previously shown to mediate in vitro cell activation induced by group B streptococcus (GBS). The present study examined the potential in vivo roles of TLR2 and MyD88 during infection with GBS. When pups were infected locally with a low bacterial dose, none of the TLR2- or MyD88-deficient mice, but all of the wild-type ones, were able to prevent systemic spread of GBS from the initial focus. Bacterial burden was higher in MyD88- than in TLR2-deficient mice, indicating a more profound defect of host defense in the former animals. In contrast, a high bacterial dose induced high level bacteremia in both mutant and wild-type mice. Under these conditions, however, TLR2 or MyD88 deficiency significantly protected mice from lethality, concomitantly with decreased circulating levels of TNF-{alpha} and IL-6. Administration of anti-TNF-{alpha} Abs to wild-type mice could mimic the effects of TLR2 or MyD88 deficiency and was detrimental in the low dose model, but protective in the high dose model. In conclusion, these data highlight a dual role of TLR2 and MyD88 in the host defense against GBS sepsis and strongly suggest TNF-{alpha} as the molecular mediator of bacterial clearance and septic shock.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. Kenzel, S. Santos-Sierra, S. D. Deshmukh, I. Moeller, B. Ergin, K. A. Fitzgerald, E. Lien, S. Akira, D. T. Golenbock, and P. Henneke
Role of p38 and Early Growth Response Factor 1 in the Macrophage Response to Group B Streptococcus
Infect. Immun., June 1, 2009; 77(6): 2474 - 2481.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
T. H. Mogensen
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Puliti, S. Uematsu, S. Akira, F. Bistoni, and L. Tissi
Toll-Like Receptor 2 Deficiency Is Associated with Enhanced Severity of Group B Streptococcal Disease
Infect. Immun., April 1, 2009; 77(4): 1524 - 1531.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Henneke, S. Dramsi, G. Mancuso, K. Chraibi, E. Pellegrini, C. Theilacker, J. Hubner, S. Santos-Sierra, G. Teti, D. T. Golenbock, et al.
Lipoproteins Are Critical TLR2 Activating Toxins in Group B Streptococcal Sepsis
J. Immunol., May 1, 2008; 180(9): 6149 - 6158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Stenzel, S. Soltek, M. Sanchez-Ruiz, S. Akira, H. Miletic, D. Schluter, and M. Deckert
Both TLR2 and TLR4 Are Required for the Effective Immune Response in Staphylococcus aureus-Induced Experimental Murine Brain Abscess
Am. J. Pathol., January 1, 2008; 172(1): 132 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Lehnardt, J. Wennekamp, D. Freyer, C. Liedtke, C. Krueger, R. Nitsch, I. Bechmann, J. R. Weber, and P. Henneke
TLR2 and Caspase-8 Are Essential for Group B Streptococcus-Induced Apoptosis in Microglia
J. Immunol., November 1, 2007; 179(9): 6134 - 6143.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Dominguez-Punaro, M. Segura, M.-M. Plante, S. Lacouture, S. Rivest, and M. Gottschalk
Streptococcus suis Serotype 2, an Important Swine and Human Pathogen, Induces Strong Systemic and Cerebral Inflammatory Responses in a Mouse Model of Infection
J. Immunol., August 1, 2007; 179(3): 1842 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Auerbuch and R. R. Isberg
Growth of Yersinia pseudotuberculosis in Mice Occurs Independently of Toll-Like Receptor 2 Expression and Induction of Interleukin-10
Infect. Immun., July 1, 2007; 75(7): 3561 - 3570.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Hoffmann, J. S. Braun, D. Becker, A. Halle, D. Freyer, E. Dagand, S. Lehnardt, and J. R. Weber
TLR2 Mediates Neuroinflammation and Neuronal Damage
J. Immunol., May 15, 2007; 178(10): 6476 - 6481.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Graveline, M. Segura, D. Radzioch, and M. Gottschalk
TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness
Int. Immunol., April 1, 2007; 19(4): 375 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Mancuso, A. Midiri, C. Biondo, C. Beninati, S. Zummo, R. Galbo, F. Tomasello, M. Gambuzza, G. Macri, A. Ruggeri, et al.
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
J. Immunol., March 1, 2007; 178(5): 3126 - 3133.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, J. H. Weis, T. G. Schwan, and J. J. Weis
Dual Role of MyD88 in Rapid Clearance of Relapsing Fever Borrelia spp.
Infect. Immun., December 1, 2006; 74(12): 6750 - 6760.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S. Santos-Sierra, D. T. Golenbock, and P. Henneke
Toll-like receptor-dependent discrimination of streptococci
Innate Immunity, October 1, 2006; 12(5): 307 - 312.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
T. H. Mogensen, S. R. Paludan, M. Kilian, and L. Ostergaard
Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns
J. Leukoc. Biol., August 1, 2006; 80(2): 267 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Lehnardt, P. Henneke, E. Lien, D. L. Kasper, J. J. Volpe, I. Bechmann, R. Nitsch, J. R. Weber, D. T. Golenbock, and T. Vartanian
A Mechanism for Neurodegeneration Induced by Group B Streptococci through Activation of the TLR2/MyD88 Pathway in Microglia
J. Immunol., July 1, 2006; 177(1): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Henneke and R. Berner
Interaction of neonatal phagocytes with group B streptococcus: recognition and response.
Infect. Immun., June 1, 2006; 74(6): 3085 - 3095.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kenzel, G. Mancuso, R. Malley, G. Teti, D. T. Golenbock, and P. Henneke
c-Jun Kinase Is a Critical Signaling Molecule in a Neonatal Model of Group B Streptococcal Sepsis.
J. Immunol., March 1, 2006; 176(5): 3181 - 3188.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Srivastava, P. Henneke, A. Visintin, S. C. Morse, V. Martin, C. Watkins, J. C. Paton, M. R. Wessels, D. T. Golenbock, and R. Malley
The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease
Infect. Immun., October 1, 2005; 73(10): 6479 - 6487.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Mancuso, A. Midiri, C. Biondo, C. Beninati, M. Gambuzza, D. Macri, A. Bellantoni, A. Weintraub, T. Espevik, and G. Teti
Bacteroides fragilis-Derived Lipopolysaccharide Produces Cell Activation and Lethal Toxicity via Toll-Like Receptor 4
Infect. Immun., September 1, 2005; 73(9): 5620 - 5627.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Henneke, S. Morath, S. Uematsu, S. Weichert, M. Pfitzenmaier, O. Takeuchi, A. Muller, C. Poyart, S. Akira, R. Berner, et al.
Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus
J. Immunol., May 15, 2005; 174(10): 6449 - 6455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.